ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

IMA Alere Inc. Common Stock

26.68
0.00 (0.00%)
16 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Alere Inc. Common Stock NYSE:IMA NYSE Ordinary Share
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 26.68 0.00 01:00:00

- Statement of Changes in Beneficial Ownership (4)

08/06/2010 11:42pm

Edgar (US Regulatory)


FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Expires: February 28, 2011
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

LEVY JOHN F
2. Issuer Name and Ticker or Trading Symbol

INVERNESS MEDICAL INNOVATIONS INC [ IMA ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

51 SAWYER ROAD, SUITE 200
3. Date of Earliest Transaction (MM/DD/YYYY)

6/4/2010
(Street)

WALTHAM, MA 02453
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   6/4/2010     M    266   A $3.87   1007   I   See Footnote   (1)
Common Stock   6/4/2010     M    125   A $5.55   118125   D    
Common Stock                  2360   I   See Footnote   (3)
Common Stock                  5201   I   See Footnote   (4)

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Common Stock Warrant (Right to Buy)   $3.87   6/4/2010     M         266    6/26/2000   6/26/2010   Common Stock   266     (2) 0   D    
Common Stock Warrant (Right to Buy)   $5.55   6/4/2010     M         125    7/31/2000   7/31/2010   Common Stock   125     (2) 0   D    

Explanation of Responses:
( 1)  These securities are owned by the John Levy and Gail Rotherberg Charitable Remainder Unitrust, of which the reporting person is the trustee.
( 2)  This derivative security does not have a price.
( 3)  These securities are held by the John Levy Family Trust, of which the reporting person is the trustee, for the benefit of the reporting person's children.
( 4)  These securities are held by the Milton L. Levy Family Ltd., of which the reporting person is a limited partner.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
LEVY JOHN F
51 SAWYER ROAD, SUITE 200
WALTHAM, MA 02453
X



Signatures
/s/ Jay McNamara, Attorney in Fact 6/8/2010
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

1 Year Alere Inc. Common Stock Chart

1 Year Alere Inc. Common Stock Chart

1 Month Alere Inc. Common Stock Chart

1 Month Alere Inc. Common Stock Chart

Your Recent History

Delayed Upgrade Clock